Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab with Cytarabine and Clofarabine in Relapsed/Refractory ALL
NCT00945815Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2010
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epratuzumab in acute lymphoblastic leukemia (ALL), sponsored by SWOG Cancer Research Network. Primary endpoint: Complete Remission. Started Sep 2010; status: completed.
02
Drugs
epratuzumab
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00945815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945815.